The FLUCOP consortium is made up of 22 partners from eight European countries consisting of:
- Academic centres (both clinical and experimental),
- Large industries (Sanofi- Pasteur, Novartis, GSK, Abbott, Crucell and AstraZeneca),
- Small-and medium-sized enterprises (SMEs),
- Centres from national and/or supranational public health bodies, non-profit organisations and regulatory authorities.